CFO transition
The Trade Desk, Inc. CFO transition: Nate Olmstead to succeed Tahnil Davis
The Trade Desk, Inc. reported in a Form 8-K filed June 1, 2026 that Nate Olmstead will succeed Tahnil Davis as chief financial officer, effective July 9, 2026.
In the filing's words
On June 1, 2026, The Trade Desk, Inc. (the “Company”) announced the appointment of Nate Olmstead, age 54, as the Company’s chief financial officer. Mr. Olmstead’s appointment as the Company’s chief financial officer will be effective as of July 9, 2026. Mr. Olmstead will replace Tahnil Davis, who is acting as the Company’s interim chief financial officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | The Trade Desk, Inc. (TTD) |
|---|---|
| Event | Transition |
| Incoming | Nate Olmstead |
| Outgoing | Tahnil Davis |
| Title in the filing | chief financial officer |
| Effective | July 9, 2026 |
| 8-K filed | June 1, 2026 |
| Internal promotion | No |
| Prior role (per filing) | senior vice president and chief financial officer, Penguin Solutions, Inc. |
| SEC CIK | 0001671933 |
The Trade Desk, Inc. reported this change in a Form 8-K, Item 5.02, filed June 1, 2026. The filing's own words are quoted above.
Other records naming Tahnil Davis
1The outgoing officer on this record, matched by name. Career line.
2026-02-27 · 10-K signature
Tahnil Davis signed Trade Desk, Inc.'s annual report as Interim Chief Financial Officer, Chief Accounting Officer (interim principal financial officer, principal accounting officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Nate Olmstead? Send a correction with the primary source.